QUEBEC CITY, Quebec — Maple syrup is just the best when you pour it on your pancakes, but a new study finds it’s time to start pouring it on everything else as well! Groundbreaking research suggests ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Analysts are bullish on Teva, which is once again Israel's most valuable company, due to an improved US generics price environment and promising branded drug pipeline. Most pf the investment bank ...

JERUSALEM, Nov 6 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit forecasts ...

Revenue in the third quarter was 12.5% higher than in the corresponding quarter of 2023. In the first nine months of 2024, Teva reported revenue of $12.3 billion, up 8.1% from the corresponding period ...

Teva said the U.S. generics’ boost was facilitated by increased sales of lenalidomide capsules, which is the copycat version of Bristol Myers Squibb’s Revlimid, and the launch of liraglutide ...

Shares of Teva Pharmaceutical (NYSE:TEVA) gained in the premarket trading on Wednesday after the generic drugmaker reported better-than-expected Q3 2024 financials and raised its full-year outlook ...

The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...

With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple ...